Summary of Purpose
The purposes of this study are to assess the prevalence of patients with a low risk of stroke or systemic embolism based on a CHA2DS2-VASc score among patients who have an AF-related thromboembolism and to identify the clinical and laboratory risk factors associated with thromboembolism in AF patients with a CHA2DS2-VA score of 0 or 1.Read More →
The following dates are available for this trial. Trial information last updated on 6 March 2018.
|6 Apr 2017||6 May 2017||20 Feb 2018||1 Jun 2018||1 Mar 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|